羚锐制药：参芪降糖胶囊拟中选全国中成药采购联盟集中带量采购

Group 1 - The product "Shenqi Jiangtang Capsule" is selected for the national medical insurance directory and the national essential drug list [1] - Lingrui Pharmaceutical (600285) announced its participation in the centralized procurement of traditional Chinese medicine [1] - The sales revenue of the product for the first three quarters of 2024 is approximately 166 million yuan, accounting for 6.01% of the company's total revenue for the same period [2]